Optimizing Complement Inhibition for Paroxysmal Nocturnal Hemoglobinuria: A Focus on Novel Therapies and Managed Care Opportunity
Optimizing Complement Inhibition for Paroxysmal Nocturnal Hemoglobinuria: A Focus on Novel Therapies and Managed Care Opportunity is organized by Healthcare Made Practical (HMP) Global.
Release Date: March 29, 2023
Expiration Date: March 29, 2024.
Description:
To be eligible for credit, participants must complete the educational activity and complete the activity evaluation form. Upon completing the activity, there will be instructions on how to complete the evaluation and print a certificate or other documentation of credit.
Learning Objectives:
After participating in this activity, learners should be better able to:
• Describe the pathogenesis, diagnosis, and burden of PNH
• Assess the latest clinical data related to the treatment of PNH, with particular focus on the limitations of traditional therapies and the promise of newer/novel complement inhibitors
• Implement evidence-based and cost-effective managed care policies that incorporate novel complement inhibitor therapies for the personalized care of patients with PNH.